HEADER TRANSFERASE 26-FEB-15 5AJQ TITLE HUMAN LOK (STK10) IN COMPLEX WITH BOSUTINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE 10; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 21-313; COMPND 5 SYNONYM: STK10, LYMPHOCYTE-ORIENTED KINASE; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PNIC28-BSA4 KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.M.ELKINS,E.SALAH,D.M.PINKAS,T.KROJER,J.KOPEC,C.BOUNTRA,A.M.EDWARDS, AUTHOR 2 S.KNAPP REVDAT 2 08-APR-15 5AJQ 1 AUTHOR REVDAT 1 11-MAR-15 5AJQ 0 JRNL AUTH J.M.ELKINS,E.SALAH,S.KNAPP JRNL TITL STK10 WITH BOSUTINIB JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0107 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU, REMARK 3 STEINER,NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 86.51 REMARK 3 DATA CUTOFF (SIGMA(F)) : NONE REMARK 3 COMPLETENESS FOR RANGE (%) : 99.37 REMARK 3 NUMBER OF REFLECTIONS : 31763 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.21890 REMARK 3 R VALUE (WORKING SET) : 0.21679 REMARK 3 FREE R VALUE : 0.25723 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.1 REMARK 3 FREE R VALUE TEST SET COUNT : 1690 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.200 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.257 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2261 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.58 REMARK 3 BIN R VALUE (WORKING SET) : 0.317 REMARK 3 BIN FREE R VALUE SET COUNT : 115 REMARK 3 BIN FREE R VALUE : 0.330 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4186 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 77 REMARK 3 SOLVENT ATOMS : 86 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 63.681 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.57 REMARK 3 B22 (A**2) : -0.83 REMARK 3 B33 (A**2) : 0.25 REMARK 3 B12 (A**2) : 0.00 REMARK 3 B13 (A**2) : 0.00 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.268 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.214 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.178 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.162 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.931 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4359 ; 0.010 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 4183 ; 0.004 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5938 ; 1.421 ; 1.959 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9614 ; 1.145 ; 2.976 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 547 ; 6.528 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 165 ;34.981 ;24.485 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 711 ;14.426 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 19 ;21.387 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 687 ; 0.087 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4823 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 896 ; 0.004 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2188 ; 3.937 ; 6.499 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2187 ; 3.937 ; 6.496 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2726 ; 6.060 ; 9.717 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2170 ; 4.370 ; 6.614 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NCS TYPE: LOCAL REMARK 3 NUMBER OF DIFFERENT NCS PAIRS : 1 REMARK 3 GROUP CHAIN1 RANGE CHAIN2 RANGE COUNT RMS WEIGHT REMARK 3 1 A 25 312 B 25 312 30634 0.08 0.05 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. REMARK 4 REMARK 4 5AJQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-FEB-15. REMARK 100 THE PDBE ID CODE IS EBI-63159. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-OCT-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.1 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97949 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33518 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.20 REMARK 200 RESOLUTION RANGE LOW (A) : 86.51 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 4.1 REMARK 200 R MERGE (I) : 0.05 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.00 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.27 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.4 REMARK 200 R MERGE FOR SHELL (I) : 0.62 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.90 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.5 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS PH 8.1, 0.1M REMARK 280 MAGNESIUM CHLORIDE, 30%(W/V) PEG 10000 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 2 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 X,-Y,-Z REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 -X,-Y+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 54.05000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 72.13500 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 54.05000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 72.13500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 19 REMARK 465 MET A 20 REMARK 465 ARG A 21 REMARK 465 GLU A 22 REMARK 465 TYR A 23 REMARK 465 THR A 69 REMARK 465 LYS A 70 REMARK 465 SER A 71 REMARK 465 LEU A 186 REMARK 465 GLN A 187 REMARK 465 LYS A 188 REMARK 465 ARG A 189 REMARK 465 ASP A 190 REMARK 465 SER A 191 REMARK 465 GLU A 313 REMARK 465 SER B 19 REMARK 465 MET B 20 REMARK 465 ARG B 21 REMARK 465 GLU B 22 REMARK 465 TYR B 23 REMARK 465 GLU B 24 REMARK 465 ILE B 67 REMARK 465 GLU B 68 REMARK 465 THR B 69 REMARK 465 LYS B 70 REMARK 465 SER B 71 REMARK 465 GLU B 72 REMARK 465 GLU B 73 REMARK 465 GLU B 74 REMARK 465 ASN B 182 REMARK 465 LEU B 183 REMARK 465 LYS B 184 REMARK 465 THR B 185 REMARK 465 LEU B 186 REMARK 465 GLN B 187 REMARK 465 LYS B 188 REMARK 465 ARG B 189 REMARK 465 ASP B 190 REMARK 465 SER B 191 REMARK 465 PHE B 192 REMARK 465 ILE B 193 REMARK 465 GLY B 194 REMARK 465 GLU B 313 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 24 CG CD OE1 OE2 REMARK 470 ARG A 28 NE CZ NH1 NH2 REMARK 470 LYS A 54 CE NZ REMARK 470 GLU A 68 CG CD OE1 OE2 REMARK 470 GLU A 72 CG CD OE1 OE2 REMARK 470 GLU A 73 CG CD OE1 OE2 REMARK 470 GLU A 74 CG CD OE1 OE2 REMARK 470 GLU A 76 CD OE1 OE2 REMARK 470 GLU A 83 CG CD OE1 OE2 REMARK 470 LYS A 181 NZ REMARK 470 LYS A 184 CE NZ REMARK 470 LYS A 301 CD CE NZ REMARK 470 LYS A 311 CG CD CE NZ REMARK 470 HIS B 25 CG ND1 CD2 CE1 NE2 REMARK 470 ARG B 27 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 28 CG CD NE CZ NH1 NH2 REMARK 470 ASP B 29 CG OD1 OD2 REMARK 470 LEU B 30 CG CD1 CD2 REMARK 470 GLU B 34 CG CD OE1 OE2 REMARK 470 GLU B 37 CG CD OE1 OE2 REMARK 470 GLU B 41 CG CD OE1 OE2 REMARK 470 LEU B 42 CG CD1 CD2 REMARK 470 PHE B 47 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 49 CG CD CE NZ REMARK 470 TYR B 51 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS B 54 CE NZ REMARK 470 LYS B 56 CD CE NZ REMARK 470 LYS B 65 CG CD CE NZ REMARK 470 GLU B 76 CG CD OE1 OE2 REMARK 470 TYR B 78 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU B 83 CG CD OE1 OE2 REMARK 470 LYS B 95 CG CD CE NZ REMARK 470 LYS B 105 CG CD CE NZ REMARK 470 GLU B 111 CG CD OE1 OE2 REMARK 470 GLU B 124 CG CD OE1 OE2 REMARK 470 LYS B 181 CG CD CE NZ REMARK 470 GLU B 207 CG CD OE1 OE2 REMARK 470 LYS B 272 CE NZ REMARK 470 LYS B 301 CG CD CE NZ REMARK 470 LYS B 311 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OG SER B 296 OG SER B 296 2555 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 25 -162.70 -167.56 REMARK 500 ASP A 44 -81.79 -113.02 REMARK 500 ALA A 46 -168.01 47.17 REMARK 500 PHE A 47 -38.60 63.87 REMARK 500 ASP A 103 -127.92 54.55 REMARK 500 GLU A 111 120.39 -39.38 REMARK 500 ASP A 126 51.28 35.42 REMARK 500 ARG A 156 -21.17 84.04 REMARK 500 ASP A 175 -56.36 81.32 REMARK 500 ILE A 233 -43.52 77.07 REMARK 500 ASP B 44 -79.51 -116.53 REMARK 500 ALA B 46 -83.67 -175.99 REMARK 500 PHE B 47 -66.28 -5.71 REMARK 500 ASP B 103 -128.44 55.14 REMARK 500 GLU B 111 119.98 -39.59 REMARK 500 ASP B 126 50.92 34.63 REMARK 500 ARG B 156 -20.29 82.63 REMARK 500 ASP B 175 -57.95 83.25 REMARK 500 ILE B 233 -43.79 77.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PHE B 176 GLY B 177 -146.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DB8 A 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DB8 B 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A1313 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A1314 DBREF 5AJQ A 21 313 UNP O94804 STK10_HUMAN 21 313 DBREF 5AJQ B 21 313 UNP O94804 STK10_HUMAN 21 313 SEQADV 5AJQ SER A 19 UNP O94804 EXPRESSION TAG SEQADV 5AJQ MET A 20 UNP O94804 EXPRESSION TAG SEQADV 5AJQ SER B 19 UNP O94804 EXPRESSION TAG SEQADV 5AJQ MET B 20 UNP O94804 EXPRESSION TAG SEQRES 1 A 295 SER MET ARG GLU TYR GLU HIS VAL ARG ARG ASP LEU ASP SEQRES 2 A 295 PRO ASN GLU VAL TRP GLU ILE VAL GLY GLU LEU GLY ASP SEQRES 3 A 295 GLY ALA PHE GLY LYS VAL TYR LYS ALA LYS ASN LYS GLU SEQRES 4 A 295 THR GLY ALA LEU ALA ALA ALA LYS VAL ILE GLU THR LYS SEQRES 5 A 295 SER GLU GLU GLU LEU GLU ASP TYR ILE VAL GLU ILE GLU SEQRES 6 A 295 ILE LEU ALA THR CYS ASP HIS PRO TYR ILE VAL LYS LEU SEQRES 7 A 295 LEU GLY ALA TYR TYR HIS ASP GLY LYS LEU TRP ILE MET SEQRES 8 A 295 ILE GLU PHE CYS PRO GLY GLY ALA VAL ASP ALA ILE MET SEQRES 9 A 295 LEU GLU LEU ASP ARG GLY LEU THR GLU PRO GLN ILE GLN SEQRES 10 A 295 VAL VAL CYS ARG GLN MET LEU GLU ALA LEU ASN PHE LEU SEQRES 11 A 295 HIS SER LYS ARG ILE ILE HIS ARG ASP LEU LYS ALA GLY SEQRES 12 A 295 ASN VAL LEU MET THR LEU GLU GLY ASP ILE ARG LEU ALA SEQRES 13 A 295 ASP PHE GLY VAL SER ALA LYS ASN LEU LYS THR LEU GLN SEQRES 14 A 295 LYS ARG ASP SER PHE ILE GLY THR PRO TYR TRP MET ALA SEQRES 15 A 295 PRO GLU VAL VAL MET CYS GLU THR MET LYS ASP THR PRO SEQRES 16 A 295 TYR ASP TYR LYS ALA ASP ILE TRP SER LEU GLY ILE THR SEQRES 17 A 295 LEU ILE GLU MET ALA GLN ILE GLU PRO PRO HIS HIS GLU SEQRES 18 A 295 LEU ASN PRO MET ARG VAL LEU LEU LYS ILE ALA LYS SER SEQRES 19 A 295 ASP PRO PRO THR LEU LEU THR PRO SER LYS TRP SER VAL SEQRES 20 A 295 GLU PHE ARG ASP PHE LEU LYS ILE ALA LEU ASP LYS ASN SEQRES 21 A 295 PRO GLU THR ARG PRO SER ALA ALA GLN LEU LEU GLU HIS SEQRES 22 A 295 PRO PHE VAL SER SER ILE THR SER ASN LYS ALA LEU ARG SEQRES 23 A 295 GLU LEU VAL ALA GLU ALA LYS ALA GLU SEQRES 1 B 295 SER MET ARG GLU TYR GLU HIS VAL ARG ARG ASP LEU ASP SEQRES 2 B 295 PRO ASN GLU VAL TRP GLU ILE VAL GLY GLU LEU GLY ASP SEQRES 3 B 295 GLY ALA PHE GLY LYS VAL TYR LYS ALA LYS ASN LYS GLU SEQRES 4 B 295 THR GLY ALA LEU ALA ALA ALA LYS VAL ILE GLU THR LYS SEQRES 5 B 295 SER GLU GLU GLU LEU GLU ASP TYR ILE VAL GLU ILE GLU SEQRES 6 B 295 ILE LEU ALA THR CYS ASP HIS PRO TYR ILE VAL LYS LEU SEQRES 7 B 295 LEU GLY ALA TYR TYR HIS ASP GLY LYS LEU TRP ILE MET SEQRES 8 B 295 ILE GLU PHE CYS PRO GLY GLY ALA VAL ASP ALA ILE MET SEQRES 9 B 295 LEU GLU LEU ASP ARG GLY LEU THR GLU PRO GLN ILE GLN SEQRES 10 B 295 VAL VAL CYS ARG GLN MET LEU GLU ALA LEU ASN PHE LEU SEQRES 11 B 295 HIS SER LYS ARG ILE ILE HIS ARG ASP LEU LYS ALA GLY SEQRES 12 B 295 ASN VAL LEU MET THR LEU GLU GLY ASP ILE ARG LEU ALA SEQRES 13 B 295 ASP PHE GLY VAL SER ALA LYS ASN LEU LYS THR LEU GLN SEQRES 14 B 295 LYS ARG ASP SER PHE ILE GLY THR PRO TYR TRP MET ALA SEQRES 15 B 295 PRO GLU VAL VAL MET CYS GLU THR MET LYS ASP THR PRO SEQRES 16 B 295 TYR ASP TYR LYS ALA ASP ILE TRP SER LEU GLY ILE THR SEQRES 17 B 295 LEU ILE GLU MET ALA GLN ILE GLU PRO PRO HIS HIS GLU SEQRES 18 B 295 LEU ASN PRO MET ARG VAL LEU LEU LYS ILE ALA LYS SER SEQRES 19 B 295 ASP PRO PRO THR LEU LEU THR PRO SER LYS TRP SER VAL SEQRES 20 B 295 GLU PHE ARG ASP PHE LEU LYS ILE ALA LEU ASP LYS ASN SEQRES 21 B 295 PRO GLU THR ARG PRO SER ALA ALA GLN LEU LEU GLU HIS SEQRES 22 B 295 PRO PHE VAL SER SER ILE THR SER ASN LYS ALA LEU ARG SEQRES 23 B 295 GLU LEU VAL ALA GLU ALA LYS ALA GLU HET DB8 A 800 36 HET DB8 B 800 36 HET CL A1313 1 HET EDO A1314 4 HETNAM EDO 1,2-ETHANEDIOL HETNAM CL CHLORIDE ION HETNAM DB8 4-[(2,4-DICHLORO-5-METHOXYPHENYL)AMINO]-6- HETNAM 2 DB8 METHOXY-7-[3-(4-METHYLPIPERAZIN-1-YL)PROPOXY] HETNAM 3 DB8 QUINOLINE-3-CARBONITRILE HETSYN EDO ETHYLENE GLYCOL HETSYN DB8 BOSUTINIB FORMUL 3 EDO C2 H6 O2 FORMUL 4 CL CL 1- FORMUL 5 DB8 2(C26 H29 CL2 N5 O3) FORMUL 6 HOH *86(H2 O) HELIX 1 1 ASP A 31 VAL A 35 1 5 HELIX 2 2 LEU A 75 CYS A 88 1 14 HELIX 3 3 VAL A 118 LEU A 125 1 8 HELIX 4 4 THR A 130 LYS A 151 1 22 HELIX 5 5 LYS A 159 GLY A 161 5 3 HELIX 6 6 GLY A 177 LYS A 184 1 8 HELIX 7 7 ALA A 200 VAL A 204 5 5 HELIX 8 8 TYR A 216 ILE A 233 1 18 HELIX 9 9 ASN A 241 SER A 252 1 12 HELIX 10 10 THR A 259 TRP A 263 5 5 HELIX 11 11 SER A 264 LEU A 275 1 12 HELIX 12 12 SER A 284 GLU A 290 1 7 HELIX 13 13 ASN A 300 ALA A 312 1 13 HELIX 14 14 ASP B 31 VAL B 35 1 5 HELIX 15 15 LEU B 75 CYS B 88 1 14 HELIX 16 16 VAL B 118 LEU B 125 1 8 HELIX 17 17 THR B 130 LYS B 151 1 22 HELIX 18 18 LYS B 159 GLY B 161 5 3 HELIX 19 19 PHE B 176 LYS B 181 1 6 HELIX 20 20 ALA B 200 VAL B 204 5 5 HELIX 21 21 TYR B 216 ILE B 233 1 18 HELIX 22 22 ASN B 241 SER B 252 1 12 HELIX 23 23 THR B 259 TRP B 263 5 5 HELIX 24 24 SER B 264 LEU B 275 1 12 HELIX 25 25 SER B 284 GLU B 290 1 7 HELIX 26 26 ASN B 300 ALA B 312 1 13 SHEET 1 AA 6 VAL A 26 ARG A 27 0 SHEET 2 AA 6 LEU A 96 HIS A 102 1 O ALA A 99 N ARG A 27 SHEET 3 AA 6 LYS A 105 GLU A 111 -1 O LYS A 105 N HIS A 102 SHEET 4 AA 6 LEU A 61 ILE A 67 -1 O ALA A 63 N ILE A 110 SHEET 5 AA 6 VAL A 50 ASN A 55 -1 O TYR A 51 N ALA A 64 SHEET 6 AA 6 TRP A 36 LEU A 42 -1 O GLU A 37 N LYS A 54 SHEET 1 AB 3 GLY A 116 ALA A 117 0 SHEET 2 AB 3 VAL A 163 MET A 165 -1 N MET A 165 O GLY A 116 SHEET 3 AB 3 ILE A 171 LEU A 173 -1 O ARG A 172 N LEU A 164 SHEET 1 BA 5 TRP B 36 GLU B 41 0 SHEET 2 BA 5 VAL B 50 ASN B 55 -1 O LYS B 52 N VAL B 39 SHEET 3 BA 5 LEU B 61 LYS B 65 -1 O ALA B 62 N ALA B 53 SHEET 4 BA 5 LYS B 105 GLU B 111 -1 O ILE B 108 N LYS B 65 SHEET 5 BA 5 LEU B 96 HIS B 102 -1 N LEU B 97 O MET B 109 SHEET 1 BB 3 GLY B 116 ALA B 117 0 SHEET 2 BB 3 VAL B 163 MET B 165 -1 N MET B 165 O GLY B 116 SHEET 3 BB 3 ILE B 171 LEU B 173 -1 O ARG B 172 N LEU B 164 SSBOND 1 CYS A 206 CYS B 206 1555 4555 2.12 CISPEP 1 ASP A 44 GLY A 45 0 1.21 CISPEP 2 ASP B 44 GLY B 45 0 3.23 SITE 1 AC1 18 LEU A 42 GLY A 43 ALA A 63 ALA A 64 SITE 2 AC1 18 LYS A 65 ILE A 110 GLU A 111 PHE A 112 SITE 3 AC1 18 CYS A 113 PRO A 114 GLY A 116 GLU A 124 SITE 4 AC1 18 ASN A 162 LEU A 164 ASP A 175 ALA A 310 SITE 5 AC1 18 HOH A2027 HOH A2056 SITE 1 AC2 10 LEU B 42 ALA B 63 LYS B 65 ILE B 108 SITE 2 AC2 10 ILE B 110 GLU B 111 PHE B 112 CYS B 113 SITE 3 AC2 10 PRO B 114 LEU B 164 SITE 1 AC3 2 ARG A 244 LYS A 248 SITE 1 AC4 5 TYR A 92 GLN A 140 GLU A 143 ILE A 297 SITE 2 AC4 5 HOH A2057 CRYST1 41.190 108.100 144.270 90.00 90.00 90.00 P 2 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024278 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009251 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006931 0.00000